Riskpilot← Back to searchSign inGet full accessTandläkare Eckersten AB
ABActiveOrg 5568548761Brogatan 3Dental practice care activities · NACE 8623Est. 20115 employees
Revenue 2025
SEK 8,8M
-10% vs 2024
EBITDA margin
34.7%
-22% vs 2024
Equity ratio
72.7%
Financial strength
Net profit 2025
SEK 2,5M
-10% vs 2024
| Revenue | SEK 8,8M | -10% |
| EBITDA | SEK 3M | -22% |
| Net profit | SEK 2,5M | -10% |
| Total assets | SEK 30,1M | +3% |
| Equity | SEK 21,9M | +6% |
| Employees | 5 | — |
Legal name
Tandläkare Eckersten AB
Org number
5568548761
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
7 juni 2011
Share capital
SEK 50 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva tandläkarpraktik, handel med värdepapper och fastighetsförvaltning samt därmed förenlig verksamhet.
Address
Brogatan 3
Phone
+4635103300
Email
michael.eckersten@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 9 672 | 10 483 | 8 589 | 10 260 | 9 309 | 9 445 | 9 756 | 8 754 |
| Staff expenses | — | — | — | — | — | — | — | −3 180 | −3 576 | −3 514 | −3 844 |
| EBITDA | 5 575 | 4 608 | 3 731 | 3 954 | 4 472 | 3 311 | 4 456 | 3 249 | 3 730 | 3 914 | 3 039 |
| Depreciation & amort. | −575 | −576 | −138 | −325 | −339 | −344 | −318 | −300 | −186 | −224 | −224 |
| EBIT | 5 000 | 4 032 | 3 593 | 3 629 | 4 133 | 2 967 | 4 138 | 2 949 | 3 544 | 3 690 | 2 815 |
| Net financials | −58 | 166 | 55 | −613 | 952 | 8 | 12 | 28 | 244 | 218 | 8 |
| Profit before tax | 3 771 | 3 088 | 2 742 | 2 831 | 4 486 | 3 202 | 4 051 | 3 011 | 3 422 | 3 599 | 3 181 |
| Tax | −846 | −694 | −623 | −716 | −934 | −725 | −879 | −664 | −773 | −854 | −704 |
| Net profit | 2 925 | 2 394 | 2 119 | 2 115 | 3 552 | 2 477 | 3 172 | 2 347 | 2 648 | 2 745 | 2 478 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 12 524 | 14 243 | 16 547 | 17 665 | 20 964 | 23 186 | 24 286 | 25 769 | 27 603 | 29 287 | 30 105 |
| Equity | 6 702 | 7 796 | 9 176 | 10 254 | 12 813 | 15 290 | 16 325 | 17 630 | 19 161 | 20 663 | 21 900 |
| Long-term debt | 255 | 200 | 0 | 0 | 0 | 0 | 0 | — | — | — | — |
| Short-term debt | 1 333 | 904 | 1 121 | 673 | 813 | 785 | 750 | 963 | 900 | 773 | 713 |
| Total debt | 1 588 | 1 104 | 1 121 | 673 | 813 | 785 | 750 | 963 | 900 | 773 | 713 |
EBITDA margin
34.7%
This company
15.8%
Market median
+120% vs market
20152025
Equity ratio
72.7%
This company
38.2%
Market median
+90% vs market
20152025
Return on equity
11.3%
This company
18.4%
Market median
+39% vs market
20152025
Net profit margin
28.3%
This company
8.1%
Market median
+249% vs market
20152025
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
20152025
Debt / equity
0.37×
This company
0.62×
Market median
+40% vs market
20152025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JÅ | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tandläkare Eckersten AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Åke Mikael Ejnarsson | Audit | 0 companies |
| Kajsa Siri Johanna Lund | Deputy Board Member | 0 companies |
| Carl Michael Henrik Eckersten | Board of Directors | 0 companies |
| Claes Göran Eckersten | Deputy Board Member | 0 companies |